{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","description":"This cluster of papers explores the intricate relationship between inflammation and cancer, focusing on the role of immunity, systemic inflammatory response, platelets, and various prognostic markers in cancer development, progression, and treatment effectiveness. It delves into the mechanisms of inflammation-induced cancer, the impact of platelets on metastasis, and the potential of inflammatory pathways as therapeutic targets.","keywords":[{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":0.3828},{"id":"https://openalex.org/keywords/platelet-to-lymphocyte-ratio","display_name":"platelet-to-lymphocyte ratio","score":0.4807},{"id":"https://openalex.org/keywords/systemic-immune-inflammation-index","display_name":"systemic immune-inflammation index","score":0.4527},{"id":"https://openalex.org/keywords/lymphocyte-to-monocyte-ratio","display_name":"lymphocyte-to-monocyte ratio","score":0.5499},{"id":"https://openalex.org/keywords/prognostic-nutritional-index","display_name":"prognostic nutritional index","score":0.4212},{"id":"https://openalex.org/keywords/monocyte-to-lymphocyte-ratio","display_name":"monocyte-to-lymphocyte ratio","score":0.3898},{"id":"https://openalex.org/keywords/systemic-inflammatory-response-index","display_name":"systemic inflammation response index","score":0.4041},{"id":"https://openalex.org/keywords/c-reactive-protein-albumin-ratio","display_name":"C-reactive protein to albumin ratio","score":0.3172},{"id":"https://openalex.org/keywords/glasgow-prognostic-score","display_name":"Glasgow Prognostic Score","score":0.6004},{"id":"https://openalex.org/keywords/preoperative-biomarkers","display_name":"preoperative biomarkers","score":0.25},{"id":"https://openalex.org/keywords/modified-glasgow-prognostic-score","display_name":"modified Glasgow Prognostic Score","score":0.6256},{"id":"https://openalex.org/keywords/systemic-inflammatory-markers","display_name":"systemic inflammatory markers","score":0.3368},{"id":"https://openalex.org/keywords/preoperative-inflammatory-markers","display_name":"preoperative inflammatory markers","score":0.6808},{"id":"https://openalex.org/keywords/systemic-inflammatory-index","display_name":"systemic inflammatory index","score":0.3851},{"id":"https://openalex.org/keywords/preoperative-inflammation","display_name":"preoperative inflammation","score":0.706},{"id":"https://openalex.org/keywords/pan-immune-inflammation-value","display_name":"pan-immune-inflammation value","score":0.4117},{"id":"https://openalex.org/keywords/advanced-lung-cancer-inflammation-index","display_name":"advanced lung cancer inflammation index","score":0.6708},{"id":"https://openalex.org/keywords/halp-score","display_name":"HALP score","score":0.3679},{"id":"https://openalex.org/keywords/inflammatory-indices","display_name":"inflammatory indices","score":0.28},{"id":"https://openalex.org/keywords/pretreatment-biomarkers","display_name":"pretreatment biomarkers","score":0.4247},{"id":"https://openalex.org/keywords/fibrinogen-to-albumin-ratio","display_name":"fibrinogen-to-albumin ratio","score":0.3259},{"id":"https://openalex.org/keywords/neutrophil-percentage-to-albumin-ratio","display_name":"neutrophil percentage-to-albumin ratio","score":0.4983},{"id":"https://openalex.org/keywords/cally-index","display_name":"CALLY index","score":0.4842},{"id":"https://openalex.org/keywords/preoperative-serum-biomarkers","display_name":"preoperative serum biomarkers","score":0.2331},{"id":"https://openalex.org/keywords/inflammation-based-prognostic-scores","display_name":"inflammation-based prognostic scores","score":0.8085}],"legacy_keywords":"Inflammation; Cancer; Immunity; Neutrophil-to-Lymphocyte Ratio; Platelets; Tumor Microenvironment; Systemic Inflammatory Response; Metastasis; Thrombosis; Prognostic Markers","ids":{"openalex":"https://openalex.org/T11355","wikipedia":"https://en.wikipedia.org/wiki/Inflammation_and_cancer"},"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"},"siblings":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers"},{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties"},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care"},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research"},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments"},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis"},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management"},{"id":"https://openalex.org/T10552","display_name":"Colorectal Cancer Screening and Detection"},{"id":"https://openalex.org/T10556","display_name":"Global Cancer Incidence and Screening"},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms"},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways"},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders"},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research"},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies"},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments"},{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts"},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases"},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research"},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions"},{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling"},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology"},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases"},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy"},{"id":"https://openalex.org/T12103","display_name":"Cancer Risks and Factors"},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections"},{"id":"https://openalex.org/T12278","display_name":"Vascular Tumors and Angiosarcomas"},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies"},{"id":"https://openalex.org/T12379","display_name":"Cancer Diagnosis and Treatment"},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis"},{"id":"https://openalex.org/T12758","display_name":"Saffron Plant Research Studies"},{"id":"https://openalex.org/T13434","display_name":"Cancer Research and Treatment"},{"id":"https://openalex.org/T14326","display_name":"Ear and Head Tumors"},{"id":"https://openalex.org/T14364","display_name":"Clusterin in disease pathology"}],"works_count":38425,"cited_by_count":531129,"works_api_url":"https://api.openalex.org/works?filter=topics.id:T11355","updated_date":"2026-10-20T03:01:21","created_date":"2024-01-23T15:27:10"}